Category: Boston Scientific
Here's a look at some of the top mergers & acquisitions stories for medical device companies this week: J&J deals Cordis to Cardinal Health for nearly $2B; Cyberonics to buy Italy's Sorin for $1.4B; Boston Scientific to buy Endo's urology portfolio for $1.65B; Nikon pushes into medtech with $400 mln Optos acquisition; Allergan CEO in line for $100M payout from Actavis deal
, Boston Scientific
, Cardinal Health
, Cordis Corp.
, Cyberonics Inc.
, Endo Health
, Johnson & Johnson
, Optos Inc.
, Sorin Group
, Allergan Inc.
Boston Scientific names former Covidien CFO Charles Dockendorff and Hologic CEO Stephen MacMillan to its board of directors.
Biolase Technology Inc.
, Boston Scientific
, Breg Inc.
, Google Inc.
, Hologic Inc.
, Penumbra Inc.
Here's a look at some of the top regulatory stories for medical device companies this week: FDA clears new version of Boston Scientific's SpyGlass; Joint FDA panel recommends OK for Avedro's eye treatment; Staar Surgical posts Q4, 2014 losses; FDA removes unregistered medical device establishments from database; FDA panel to review brain aneurysm devices
Boston Scientific confirms speculation with a $1.65 billion bid for Endo International's urology business, not including its star-crossed American Medical Systems pelvic mesh business.
Boston Scientific says the FDA cleared the SpyGlass DS version of its cholangioscopy and pancreatoscopy device.
Boston Scientific (NYSE:BSX) said the FDA granted 510(k) clearance for the latest iteration in its line of cholangioscopy and pancreatoscopy devices, the SpyGlass DS.
Endo Health Solutions may have found a buyer for its American Medical Systems subsidiary in Boston Scientific, according to a Reuters report.
Endo International, PLC (NSDQ:ENDP) may have found a buyer for its American Medical Systems subsidiary after months of speculation that the Irish pharma company had put its medical device business on the block.
C. R. Bard is reportedly close to settling a suit filed in a West Virginia federal court by a woman who claimed she was injured by the company's pelvic-mesh device, Avaulta Plus.
C.R. Bard (NYSE:BCR) is reportedly close to settling a suit filed in West Virginia federal court by a woman who claimed she was injured by the company's pelvic-mesh device, Avaulta Plus.